Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

INSULIN - ANVISA Registration 81246986836

Access comprehensive regulatory information for INSULIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81246986836 and manufactured by ORTHO-CLINICAL DIAGNOSTICS. The registration is held by ORTHO CLINICAL DIAGNÓSTICS DO BRASIL PRODUTOS PARA SAÚDE LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81246986836
Registration Details
ANVISA Registration Number: 81246986836
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família de Produtos para Imunodiagnóstico VITROS – Reagente e Calibrador para teste de quantificação de Insulina
Risk Class II

Registration Details

81246986836

25351654009201732

21921393000146

Company Information

United Kingdom
PT: REINO UNIDO

Dates and Status

Feb 05, 2018

VIGENTE

09/18/2025 19:00:01